Stock Track | Philip Morris Soars 5.02% in Pre-Market on Strong Q1 Earnings Beat and FDA Re-Authorization of IQOS

Stock Track04-22

Philip Morris International's stock soared 5.02% in pre-market trading on Wednesday, following the release of its first-quarter financial results and positive regulatory news.

The tobacco giant reported adjusted earnings of $1.96 per share for Q1, beating analyst estimates of $1.83. Revenue rose 9.1% to $10.15 billion, also surpassing expectations of $9.91 billion. The company attributed the strong performance to significant growth in its international smoke-free business, led by its IQOS heated tobacco device, which saw double-digit shipment volume gains. This growth helped offset weaker performance in the U.S. market.

Further bolstering investor sentiment was the U.S. Food and Drug Administration's re-authorization of IQOS as a modified risk tobacco product, covering the IQOS 2.4, IQOS 3.0, and Heets tobacco stick series. This regulatory endorsement strengthens the commercial outlook for Philip Morris's smoke-free portfolio. Additionally, the company provided full-year adjusted EPS guidance of $8.36 to $8.51, aligning with analyst expectations, and noted it does not assume a prolonged impact from Middle East conflicts on its business.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1172467438?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-22 21:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1172467438","market":"hk","top_or_hot":-1,"title":"Stock Track | Philip Morris Soars 5.02% in Pre-Market on Strong Q1 Earnings Beat and FDA Re-Authorization of IQOS","media":"Stock Track","content":"<p>Philip Morris International's stock soared 5.02% in pre-market trading on Wednesday, following the release of its first-quarter financial results and positive regulatory news.</p><p>The tobacco giant reported adjusted earnings of $1.96 per share for Q1, beating analyst estimates of $1.83. Revenue rose 9.1% to $10.15 billion, also surpassing expectations of $9.91 billion. The company attributed the strong performance to significant growth in its international smoke-free business, led by its IQOS heated tobacco device, which saw double-digit shipment volume gains. This growth helped offset weaker performance in the U.S. market.</p><p>Further bolstering investor sentiment was the U.S. Food and Drug Administration's re-authorization of IQOS as a modified risk tobacco product, covering the IQOS 2.4, IQOS 3.0, and Heets tobacco stick series. This regulatory endorsement strengthens the commercial outlook for Philip Morris's smoke-free portfolio. Additionally, the company provided full-year adjusted EPS guidance of $8.36 to $8.51, aligning with analyst expectations, and noted it does not assume a prolonged impact from Middle East conflicts on its business.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Philip Morris Soars 5.02% in Pre-Market on Strong Q1 Earnings Beat and FDA Re-Authorization of IQOS</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Philip Morris Soars 5.02% in Pre-Market on Strong Q1 Earnings Beat and FDA Re-Authorization of IQOS\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-22 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Philip Morris International's stock soared 5.02% in pre-market trading on Wednesday, following the release of its first-quarter financial results and positive regulatory news.</p><p>The tobacco giant reported adjusted earnings of $1.96 per share for Q1, beating analyst estimates of $1.83. Revenue rose 9.1% to $10.15 billion, also surpassing expectations of $9.91 billion. The company attributed the strong performance to significant growth in its international smoke-free business, led by its IQOS heated tobacco device, which saw double-digit shipment volume gains. This growth helped offset weaker performance in the U.S. market.</p><p>Further bolstering investor sentiment was the U.S. Food and Drug Administration's re-authorization of IQOS as a modified risk tobacco product, covering the IQOS 2.4, IQOS 3.0, and Heets tobacco stick series. This regulatory endorsement strengthens the commercial outlook for Philip Morris's smoke-free portfolio. Additionally, the company provided full-year adjusted EPS guidance of $8.36 to $8.51, aligning with analyst expectations, and noted it does not assume a prolonged impact from Middle East conflicts on its business.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PM","symbol_name":"菲利普莫里斯","start_time":0,"source_url":"","article_id":"1172467438","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1172467438","pubTimestamp":1776866342,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Philip Morris International's stock soared 5.02% in pre-market trading on Wednesday, following the release of its first-quarter financial results and positive regulatory news.The tobacco giant...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PM":"菲利普莫里斯"},"translate_title":"个股追踪|菲利普莫里斯盘前大涨5.02%，因Q1盈利强劲且FDA重新授权IQOS","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PM":1},"content_text":"Philip Morris International's stock soared 5.02% in pre-market trading on Wednesday, following the release of its first-quarter financial results and positive regulatory news.The tobacco giant reported adjusted earnings of $1.96 per share for Q1, beating analyst estimates of $1.83. Revenue rose 9.1% to $10.15 billion, also surpassing expectations of $9.91 billion. The company attributed the strong performance to significant growth in its international smoke-free business, led by its IQOS heated tobacco device, which saw double-digit shipment volume gains. This growth helped offset weaker performance in the U.S. market.Further bolstering investor sentiment was the U.S. Food and Drug Administration's re-authorization of IQOS as a modified risk tobacco product, covering the IQOS 2.4, IQOS 3.0, and Heets tobacco stick series. This regulatory endorsement strengthens the commercial outlook for Philip Morris's smoke-free portfolio. Additionally, the company provided full-year adjusted EPS guidance of $8.36 to $8.51, aligning with analyst expectations, and noted it does not assume a prolonged impact from Middle East conflicts on its business.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1172467438","isCrawlerRequest":true}